Evaluation of patients with head and neck cancer by means of 99mTc-Glucarate
Source: Journal of Nuclear Medicine Technology Volume 37, Number 4, 2009 229-232 Authors: Juan P. Gambini et al. Preliminary findings have suggested that 99mTc-glucarate has tumor-seeking properties. The purpose of this study was to explore the potential of this tracer to evaluate malignant head and neck tumors by means of SPECT/CT software fusion imaging. Methods: Eleven male patients with advanced head and neck carcinoma were included in the study: 9 with locally advanced disease and 2 with clinical suspicion of local relapse. Scanning started 3–6 h after the injection of 1,110 MBq of 99mTc-glucarate. Planar and SPECT images of the head, neck, and thorax were acquired. Three-dimensional images were also coregistered with CT. Results: We found 99mTc-glucarate uptake in all suspected lesions. SPECT/CT fusion imaging was helpful in all cases for topographically localizing the tracer foci. Conclusion: 99mTc-glucarate can be considered a potential tracer for the evaluation of patients with head and neck tumors. Authors: Juan P. Gambini1, Margarita Nuñez2, Pablo Cabral3, Martín Lafferranderie4, Javier Noble5, Eduardo Corchs5, Ricardo D'Albora4, Eduardo Savio6, Lucía Delgado7 and Omar Alonso1,2 Authors' affiliations: 1 Nuclear Medicine Center, Clinical Hospital, University of Uruguay, Montevideo, Uruguay; 2 School of Medical Technology, Nuclear Medicine Technology Program, University of Uruguay, Montevideo, Uruguay; 3 Nuclear Investigations Center, School of Science, University of Uruguay, Montevideo, Uruguay; 4 Department of Otorhinolaryngology, Clinical Hospital, University of Uruguay, Montevideo, Uruguay; 5 Department of Radiology, Clinical Hospital, University of Uruguay, Montevideo, Uruguay; 6 Department of Radiochemistry, School of Chemistry, University of Uruguay, Montevideo, Uruguay; [...]